Protective Agents
Showing 1 - 25 of 8,256
Closely Grouped, Iterative Exposures to Suxamethonium During ECT
Recruiting
- Depression
- +2 more
- Iterative exposure to suxamethonium during ECT sessions
-
Paris, FranceSaint-Antoine Hospital
Apr 4, 2022
Personal Protective Equipment Trial in Boston, New York (Transparent, reusable respirator)
Recruiting
- Personal Protective Equipment
- Transparent, reusable respirator
-
Boston, Massachusetts
- +2 more
Aug 2, 2021
Kidney Transplant, Type 2 Diabetes Trial in United States (Empagliflozin)
Not yet recruiting
- Kidney Transplant
- Type 2 Diabetes
-
Iowa City, Iowa
- +3 more
Aug 22, 2023
Stimulant Overdose in Medicaid Population: Who is at Risk, and
Active, not recruiting
- Stimulant Overdose
- Aim 1 (case-cohort study)
- +2 more
-
Philadelphia, PennsylvaniaUNIVERSITY OF PENNSYLVANIA Perelman SCHOOLS OF MEDICINE
Aug 4, 2023
Free Gingival Graft Trial in Cairo (Flowble resin composite stent, periodontal pack)
Recruiting
- Free Gingival Graft
- Flowble resin composite stent
- periodontal pack
-
Cairo, Manial, EgyptFaculty of dentistry, Cairo univesity
Mar 9, 2023
Pathogenesis of Autoimmune/Connective Tissue Diseases
Completed
- Autoimmune/Connective Tissue Diseases
- +3 more
-
Bethesda, MarylandNational Institute of Environmental Health Sciences (NIEHS), 900
Jan 25, 2023
Anesthesia, Exhaled Nitric Oxide, Eosinophil Blood Count Trial in Athens (maintenance with sevoflurane, maintenance with
Completed
- Anesthesia
- +2 more
- maintenance with sevoflurane
- maintenance with propofol
-
Athens, GreeceAretaieion University Hospital
Jan 30, 2022
COVID-19, SARS-CoV2 Infection Trial in New Haven (Neosporin, Vaseline)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Neosporin
- Vaseline
-
New Haven, ConnecticutYale University
Sep 12, 2022
Prevention or Reduction of HIV Risk Behavior, Prevention or Reduction of Intimate Partner Violence Trial in Cape Town (Schools
Recruiting
- Prevention or Reduction of HIV Risk Behavior
- Prevention or Reduction of Intimate Partner Violence
- Schools Championing Safe South Africa
-
Cape Town, South AfricaSouth African Medical Research Council
May 19, 2023
The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive
Completed
- The Main Focus of This Study is to Evaluate the Safety of Zingiber Officinale L. Tablets as Hypolipidemic Agent in Hypertensive Patients
- Zingiber officinale L. tablets
- Simvastatin 20mg
-
Karachi, Sindh, PakistanAlkhidmat Hospital
Jan 11, 2023
Erythema, Maceration, Lesion Skin Trial in Lincoln (DriGo Skin Protectant Textile)
Enrolling by invitation
- Erythema
- +3 more
- DriGo Skin Protectant Textile
-
Lincoln, NebraskaBryan Medical Center
Feb 20, 2023
Healthy Volunteers Trial in Charlottesville (human rhinovirus, no intervention)
Completed
- Healthy Volunteers
- human rhinovirus
- no intervention
-
Charlottesville, VirginiaUniversity of Virginia
Jun 2, 2022
Respiratory Distress Syndrome, Adult Trial in United States (Hypothermia, Neuromuscular Blocking Agents, Standard of care)
Recruiting
- Respiratory Distress Syndrome, Adult
- Hypothermia
- +2 more
-
Atlanta, Georgia
- +14 more
Oct 5, 2022
Rectal Injury Trial in Nanjing (TH-SC01(Umbilical cord mesenchymal stem cells))
Recruiting
- Rectal Injury
- TH-SC01(Umbilical cord mesenchymal stem cells)
-
Nanjing, Jiangsu, ChinaJinling Hospital, China
Jul 10, 2023
Covid19, SARS-CoV Infection Trial in Johannesburg (Nitazoxanide, Sofosbuvir/Daclatasvir)
Completed
- Covid19
- SARS-CoV Infection
-
Johannesburg, Gauteng, South Africa
- +1 more
Jun 6, 2022
Skin Hydration in Healthy Volunteers Trial in Northfield (Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™
Completed
- Skin Hydration in Healthy Volunteers
- Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectant
-
Northfield, IllinoisMedline Industries, LP
Feb 23, 2023
Diabetic Foot Ulcer Trial (Omeza collagen matrix, Omeza lidocaine lavage, Omeza skin protectant)
Not yet recruiting
- Diabetic Foot Ulcer
- Omeza collagen matrix, Omeza lidocaine lavage, Omeza skin protectant
- (no location specified)
Sep 28, 2022
Sunscreening Agents Trial in Schenefeld (Physiogel Daily Defence Protective Day Cream Light, ISO 24444:2010 P3 Standard
Completed
- Sunscreening Agents
- Physiogel Daily Defence Protective Day Cream Light
- ISO 24444:2010 P3 Standard Sunscreen
-
Schenefeld, Schleswig-Holstein, GermanyGSK Investigational Site
Jan 15, 2019
Skin Condition Trial in Cheras, Petaling Jaya (Rice ceramide supplementation)
Completed
- Skin Condition
- Rice ceramide supplementation
-
Cheras, Kuala Lumpur, Malaysia
- +1 more
Sep 27, 2022
Pollution; Exposure, Health Behavior Trial in London (Alternative health advice)
Completed
- Pollution; Exposure
- Health Behavior
- Alternative health advice
-
London, United KingdomKing' College London
Sep 23, 2021
Stroke, Acute Trial (OTR4132MD)
Recruiting
- Stroke, Acute
- OTR4132MD
-
Grenoble, Auvergne Rhône Alpes, France
- +2 more
Oct 24, 2022
Aging, Inflammation Trial in Chicago (Typhoid Vaccine, Ascorbic Acid)
Terminated
- Aging
- Inflammation
- Typhoid Vaccine
- Ascorbic Acid
-
Chicago, IllinoisIntegrative Physiology Laboratory, Suite 158
Oct 15, 2021